Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Eagle Pharmaceuticals, Inc. (EGRX)

« Back to company index

EGRX Chatter Timeline

Stock Ticker for EGRX

Most Active Tweeters for EGRX

UserTweets
@whatsonthorold2 4
@bibeypost_stock 4
@reurope_stock 4
@MareaInformativ 4
@ZolmaxNews 4

Recent Tweets for EGRX

ZolmaxNews @ZolmaxNews
Eagle Pharmaceuticals Inc $EGRX Given Average Recommendation of “Buy” by Analysts https://t.co/osSAUlZgnS
July 15th 2018, 4:07pm
ledgerzette @ledgerzette
Eagle Pharmaceuticals Inc $EGRX Receives $87.50 Consensus Target Price from Brokerages https://t.co/uU6wwHN1io
July 15th 2018, 4:07pm
dakotafinancial @dakotafinancial
Eagle Pharmaceuticals Inc $EGRX Receives $87.50 Average Price Target from Analysts https://t.co/EhH5ZxsPKr
July 15th 2018, 3:07pm
bibeypost_stock @bibeypost_stock
Eagle Pharmaceuticals, Inc. $EGRX Sets 52-Week High; Strong Momentum for Holders - https://t.co/rflJarDmkK
July 15th 2018, 10:07am
reurope_stock @reurope_stock
What's in Eagle Pharmaceuticals, Inc. $EGRX After Reaching 52-Week High? https://t.co/7dlByTgHjO
July 15th 2018, 10:07am
ThisLincolnian @ThisLincolnian
ValuEngine Upgrades Eagle Pharmaceuticals $EGRX to Buy https://t.co/j68cceQ3FE
July 15th 2018, 3:07am
dispatchtribune @dispatchtribune
Eagle Pharmaceuticals $EGRX Lifted to “Strong-Buy” at Zacks Investment Research https://t.co/91qPYH8qYy
July 14th 2018, 11:07pm
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals $EGRX Stock Rating Upgraded by Zacks Investment Research https://t.co/EQUSbgzkxI
July 14th 2018, 11:07pm
bibeypost_stock @bibeypost_stock
Could Eagle Pharmaceuticals, Inc. $EGRX Lose its Strength? The Stock Reaches 52-Week High - https://t.co/s8TsfTzRJP
July 13th 2018, 11:07am
mmahotstuff1 @mmahotstuff1
Is Buying 52-Week Stock Like Eagle Pharmaceuticals, Inc. $EGRX a Winning Strategy? - https://t.co/G8ovtxFrXB
July 13th 2018, 11:07am
whatsonthorold2 @whatsonthorold2
Eagle Pharmaceuticals, Inc. $EGRX Can't Be More Hot. Just Reaches 52-Week High - https://t.co/U3ReA5cZv9
July 13th 2018, 11:07am
reurope_stock @reurope_stock
Analysts See $0.85 EPS for Eagle Pharmaceuticals, Inc. $EGRX https://t.co/xGcrqpVZ3A
July 13th 2018, 10:07am
WeekHerald @WeekHerald
Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/CvCUdXVuqZ
July 13th 2018, 2:07am
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals $EGRX Raised to “Strong-Buy” at Zacks Investment Research https://t.co/Hnnf4Sk8ox
July 13th 2018, 2:07am
EnterpriseLeade @EnterpriseLeade
Analysts Expect Eagle Pharmaceuticals Inc $EGRX Will Announce Quarterly Sales of $51.50 Million https://t.co/sXKYQZdMst
July 12th 2018, 3:07pm
TranscriptDaily @TranscriptDaily
Eagle Pharmaceuticals Inc $EGRX Expected to Post Earnings of $0.96 Per Share https://t.co/KhKVCN6Jw7
July 12th 2018, 2:07pm
TranscriptDaily @TranscriptDaily
Eagle Pharmaceuticals $EGRX Stock Rating Upgraded by Zacks Investment Research https://t.co/30WdtI9mlP
July 12th 2018, 8:07am
bibeypost_stock @bibeypost_stock
How Analysts Feel About Eagle Pharmaceuticals, Inc. $EGRX? - https://t.co/Y7DLfvY2BD
July 12th 2018, 7:07am
reurope_stock @reurope_stock
Were Analysts Bullish Eagle Pharmaceuticals, Inc. $EGRX This Week? https://t.co/4upRJhjMyj
July 12th 2018, 7:07am
ZolmaxNews @ZolmaxNews
Eagle Pharmaceuticals $EGRX Sets New 12-Month High at $81.46 https://t.co/5LqcUOAHVd
July 12th 2018, 5:07am
ConsumerFeed @ConsumerFeed
Eagle Pharmaceuticals $EGRX Raised to Buy at ValuEngine https://t.co/TtUJKtWZT9
July 12th 2018, 2:07am
ZolmaxNews @ZolmaxNews
Eagle Pharmaceuticals $EGRX Raised to Strong-Buy at Zacks Investment Research https://t.co/YFmDeZIQSb
July 11th 2018, 11:07pm
mmahotstuff1 @mmahotstuff1
Does Eagle Pharmaceuticals, Inc. $EGRX Have More Gas After Achieving 52-Week High? - https://t.co/DfysGf1Zbw
July 11th 2018, 10:07am
whatsonthorold2 @whatsonthorold2
Will Eagle Pharmaceuticals, Inc. $EGRX Run Out of Steam Soon? - https://t.co/bD2oQ3Tu2X
July 11th 2018, 10:07am
TickerReport @TickerReport
Eagle Pharmaceuticals $EGRX Upgraded to Buy at ValuEngine https://t.co/7JfLpfloAV
July 11th 2018, 7:07am
WatchlistN @WatchlistN
Eagle Pharmaceuticals $EGRX Upgraded at ValuEngine https://t.co/KpyxBKwgxf
July 10th 2018, 10:07pm
MareaInformativ @MareaInformativ
Eagle Pharmaceuticals $EGRX Hits New 12-Month High at $81.46 https://t.co/UCzND58kFS
July 10th 2018, 4:07pm
billgunderson @billgunderson
Momentum stock of the day. $EGRX #66 rank overall. No current posiition.
July 10th 2018, 2:07pm
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals Inc $EGRX Given Consensus Rating of “Buy” by Brokerages https://t.co/2t4MZxRRbS
July 10th 2018, 10:07am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals Inc $EGRX Given Consensus Rating of “Buy” by Brokerages https://t.co/pgD8WL47BP #stocks
July 10th 2018, 10:07am
MareaInformativ @MareaInformativ
Eagle Pharmaceuticals Inc $EGRX Given Consensus Rating of “Buy” by Brokerages https://t.co/9gMIgsj7EW
July 10th 2018, 10:07am
ConsumerFeed @ConsumerFeed
Eagle Pharmaceuticals Inc $EGRX Expected to Post Earnings of $0.96 Per Share https://t.co/MWeQU2XaWr
July 10th 2018, 8:07am
1stOncology @1stOncology
FDA Grants Eagle Seven Year #OrphanDrug Exclusivity for #BENDEKA (bendamustine hydrochloride injection) $EGRX https://t.co/LrJC2tPRuC
July 10th 2018, 3:07am
hotpennyalerts @hotpennyalerts
FDA Grants $EGRX Seven Years of Orphan Drug Exclusivity in the U.S. for BENDEKA https://t.co/XG1KuFE65O
July 9th 2018, 11:07pm
MaisaCorp @MaisaCorp
$EGRX FDA Grants Eagle Pharmaceuticals Seven-Year Orphan Drug Exclusivity for BENDEKA
July 9th 2018, 3:07pm
MarketCurrents @MarketCurrents
FDA grants Eagle seven year orphan drug exclusivity for BENDEKA https://t.co/khhe1Z9yS0 $EGRX
July 9th 2018, 9:07am
EquityEarl @EquityEarl
RT @BioStocks: $EGRX FDA Grants Seven Year Orphan Drug Exclusivity for BENDEKA
July 9th 2018, 9:07am
Briefingcom @Briefingcom
$EGRX: Eagle Pharma: FDA has granted seven years of orphan drug exclusivity in the U.S., for BENDEKA https://t.co/lLsU8a6pbF
July 9th 2018, 9:07am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $EGRX (+0.0% pre) FDA Grants Eagle Seven Year Orphan Drug Exclusivity for BENDEKA - BW https://t.co/0sGwQrtVZ9
July 9th 2018, 8:07am
OpenOutcrier @OpenOutcrier
$EGRX (+0.0% pre) FDA Grants Eagle Seven Year Orphan Drug Exclusivity for BENDEKA - BW https://t.co/0sGwQrtVZ9
July 9th 2018, 8:07am
MrCDanso @MrCDanso
The Eagle ? is taking off again. $EGRX https://t.co/G7a5sXqPiv
July 9th 2018, 7:07am
MonckyD @MonckyD
RT @odibro: $EGRX FDA Grants 7 year Orphan Drug Exclusivity for BENDEKA
July 9th 2018, 7:07am
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/o7ZbssFvBA
July 9th 2018, 7:07am
confcalltran @confcalltran
Fda Grants Eagle Seven Year Orphan Drug Exclusivity For Bendeka (Bendamustine Hydrochloride Inj https://t.co/KgEUhdgiqI $EGRX
July 9th 2018, 7:07am
odibro @odibro
$EGRX FDA Grants 7 year Orphan Drug Exclusivity for BENDEKA
July 9th 2018, 7:07am
BioStocks @BioStocks
$EGRX FDA Grants Seven Year Orphan Drug Exclusivity for BENDEKA
July 9th 2018, 7:07am
MareaInformativ @MareaInformativ
Zacks: Brokerages Anticipate Eagle Pharmaceuticals Inc $EGRX Will Announce Quarterly Sales of $51.50 Million https://t.co/LCrpnvhI8a
July 9th 2018, 6:07am
WatchlistN @WatchlistN
Zacks: Brokerages Anticipate Eagle Pharmaceuticals Inc $EGRX Will Announce Quarterly Sales of $51.50 Million https://t.co/CEDZvVF4Lc
July 9th 2018, 3:07am
TickerReport @TickerReport
Eagle Pharmaceuticals Inc $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/3QB5zhtOTH
July 9th 2018, 2:07am
MareaInformativ @MareaInformativ
$0.96 EPS Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/DXGHz87SQE
July 7th 2018, 2:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.